Mai Capital Management Krystal Biotech, Inc. Put Options Transaction History
Mai Capital Management
- $13.2 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KRYS
# of Institutions
300Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$708 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$516 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$472 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$229 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$158 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.6B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...